Product Details
| Product Name: Ixazomib Citrate | CAS No.: 1239908-20-3 |
| Min. Order: 10g | Purity: 99% |
| Supply Ability: 10kgs | Release date: 2025/09/22 |
| Name | Ixazomib citrate |
|---|---|
| Synonyms | 2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid; MLN 9708 |
| Molecular Structure |  |
| Molecular Formula | C20H23BCl2N2O9 |
| Molecular Weight | 517.12 |
| CAS Registry Number | 1239908-20-3 |
Company Profile Introduction
Cangzhou Kangrui Pharma Tech Co. Ltd., located in the southeast of Hebei Province, is a scientific and technological innovation company integrating the production, research and development, and sales of pharmaceutical intermediates.
Cangzhou Kangrui Pharma Tech Co. Ltd., has 5 researchers including 2 doctors and 3 masters. The whole team have many years of industry background in chemical synthesis and generic and innovative drug development.
Cangzhou Kangrui Pharma Tech Co. Ltd., has 300m2?R&D center located at Zhi Fang Tou Industrial Park, as well as several cooperative manufacturing.
Cangzhou Kangrui Pharma Tech Co. Ltd., takes the international advanced management mode to operate well-equipped laboratories for synthesis, analysis detection. Cang Zhou Kangrui can provide clients with high quality service based on well-developed research and development system, quality management system and production conditions.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1520.00/25mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-07-31 | |
| $96.00/5mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-12-02 | |
| $0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2024-04-17 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-09-13 | |
| $1.00/1kg |
VIP8Y
|
Career Henan Chemical Co
|
2018-12-20 |
China- Since: 2022-08-22
- Address: Building 1, Jinding Field, Yuhe West Road, Yunhe District, Cangzhou City, Hebei Province, China 2-23
INQUIRY